GlassScriptPhysician profile
Brian A Arvidson
NPI 1508050337
$12,109.27
in general payments reported to CMS, 2019-2025
14 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.57 · 2022: $5,662 · 2023: $3,910 · 2024: $2,328 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $5,861 · Food and Beverage: $514.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $5,861.34 |
| Food and Beverage | $514.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $11,439.99 | 2022-2024 | Humphrey Field Analyzer (Hfa3) |
| Oyster Point Pharma, INC. | $125.51 | 2022-2024 | Tyrvaya |
| Glaukos Corporation | $125.40 | 2019-2025 | Istent Infinite, Idosetr, Idose |
| Alcon Vision LLC | $118.59 | 2024 | Clareon |
| Abbvie INC. | $59.90 | 2022-2024 | Durysta |
| Bausch & Lomb Americas INC. | $45.00 | 2025 | Miebo, Xiidra, Envista Envy Iol |
| Sight Sciences, INC. | $40.84 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $35.63 | 2019-2025 | Tecnis Iol |
| Rayner Intraocular Lenses Limited | $27.54 | 2024 | Rayone Spheric, Rayone Emv, Rayner Cataract Set 1 |
| Biotissue Holdings INC. | $26.32 | 2025 | |
| Rxsight INC | $19.84 | 2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Eyevance Pharmaceuticals LLC | $16.50 | 2019 | |
| Aerie Pharmaceuticals, INC. | $14.19 | 2019 | |
| Harrow Eye, LLC | $14.02 | 2025 | Triesence |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Arvidson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.